Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-07-02-Speech-1-111-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-07-02"^^xsd:date2
dcterms:Is Part Of	lp_eu:Customs enforcement of intellectual property rights (debate)2
dcterms:Language	"el"^^xsd:language2
lpv:document identification number	"en.20120702.19.1-111-000"2
lpv:hasSubsequent	lp_eu:2012-07-02-Speech-1-112-0002
lpv:speaker	lp:Sylvana Rapti2
lpv:spokenAs	member; EMPL (2012-01-19--2014-06-30)3 unknown; Panhellenic Socialist Movement (2009-07-14--2014-06-30)3 substitute; PETI (2012-01-19--2014-06-30)3 substitute; IMCO (2012-01-19--2014-06-30)3 substitute; Delegation for relations with the Mashreq countries (2009-09-16--2014-06-30)3 member; S&D (2009-07-14--2014-06-30)3 member; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; Delegation to the EU-Chile Joint Parliamentary Committee (2009-09-16--2014-06-30)3
lpv:translated text	"Mr President, the subject of today’s debate has two dimensions: a trade and economic dimension and an ethical dimension. Imitation products take their toll on the economy, employment and consumer safety and protection. We must not forget this dual dimension of the subject of today’s debate. We are making customs and customs officers responsible for taking decisions of substance. I think that we need to look at this very carefully because, on the one hand, we need controls in keeping with the letter of the law and, at the same time, we need flexibility. A typical example of where flexibility is needed is with generic medicines. To put it bluntly, and to call a spade a spade, I really must emphasise that large companies are using imitation products as a pretext and opportunity or loophole to stop generic medicines destined for Africa. We really must look at this very carefully."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph